Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells

Investigators identified circulating tumor cell-biomarkers and effective combinations of tumor-initiating stem-like cell-specific, repurposed FDA-approved drugs.